This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferri, C Articles by Pasero, G Search for Related Content PubMed PubMed Citation Articles by Ferri, C Articles by Pasero, G Social Bookmarking                   What's this?

Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders

L La Civita

G Longombardo

Rheumatology Unit, Istituto Patologia Medica I, University of Pisa, Italy

A L Zignego

Istituto Medicina Interna, University of Florence, Italy

G Pasero

Rheumatology Unit, Istituto Patologia Medica I, University of Pisa, Italy

Mixed cryoglobulinaemia (MC) is a systemic vasculitis, secondary to the deposition in small and medium-sized blood vessels of circulating immune complexes, mainly the cryoglobulins, and complement. MC is characterised by a typical clinical triad (purpura, weakness, arthralgias) and by one or more organ involvement: chronic hepatitis, glomerulonephritis, peripheral neuropathy, skin ulcers and diffuse vasculitis. In a limited number of MC patients, a malignancy, that is B-cell non-Hodgkin's lymphoma or hepatocellular carcinoma, may also develop.

Hepatitis C virus (HCV) infection has been found in the majority of patients with MC; the frequency of HCV markers (91%) was significantly higher than other rheumatic diseases (6.4%), namely systemic lupus, Sjùgren's syndrome, rheumatoid arthritis and systemic sclerosis, or healthy controls (1.2%). The HCV infection of lymphoid tissues may represent the remote event leading to B-lymphocyte proliferation responsible for autoantibodies and immune-complex production. In a similar way, HCV infection may also be involved in the pathogenesis of other autoimmune (glomerulonephritis, thyroiditis, lung fibrosis, autoimmune hepatitis, porphyria cutanea tarda) and lymphoproliferative disorders (monoclonal gammopathies, B-cell lymphomas). MC shares numerous clinico-serological and pathological features with the above disorders. HCV seems to be their common etiological agent; however, a variable combination of unknown co-factors (infectious, genetic, environmental) should be determinant for the appearance of different clinical patterns.

Key Words: mixed cryoglobulinaemia • systemic vasculitis • hepatitis C virus • lymphoma • hepatocellular carcinoma

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Moorman, M. Saad, S. Kosseifi, and G. Krishnaswamy Hepatitis C Virus and the Lung: Implications for Therapy Chest, October 1, 2005; 128(4): 2882 - 2892. [Abstract] [Full Text] [PDF]

				P Lamprecht, C Lerin-Lozano, H Merz, R H Dennin, A Gause, J Voswinkel, S O Peters, O Gutzeit, A C Arlt, W Solbach, et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis Ann Rheum Dis, December 1, 2003; 62(12): 1230 - 1233. [Abstract] [Full Text] [PDF]

				C Ferri, A L Zignego, and S A Pileri Cryoglobulins J. Clin. Pathol., January 1, 2002; 55(1): 4 - 13. [Abstract] [Full Text] [PDF]

				L La Civita, P Fadda, I Olivieri, and C Ferri Cryoglobulinaemic vasculitis as presenting manifestation of infective endocarditis Ann Rheum Dis, January 1, 2002; 61(1): 89 - 90. [Full Text] [PDF]

				M. Ramos-Casals, O. Trejo, M. Garcia-Carrasco, R. Cervera, and J. Font Mixed cryoglobulinemia: new concepts Lupus, February 1, 2000; 9(2): 83 - 91. [Abstract] [PDF]

				A. PERL Mechanisms of viral pathogenesis in rheumatic disease Ann Rheum Dis, August 1, 1999; 58(8): 454 - 461. [Full Text]